Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
申请人:NPS PHARMACEUTICALS, INC.
公开号:US20030013715A1
公开(公告)日:2003-01-16
The present invention provides compounds, and pharmaceutical compositions containing those compounds, that are active at metabotropic glutamate receptors. The compounds are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
The present invention relates to novel compounds of formula (IA), which are JAK3 Kinase inhibitors, methods for their preparation and pharmaceutical compositions comprising them.